Holen Sie sich die Stockscreener-App
2.37
14.49%
0.30
Handel nachbörslich:
2.45
0.08
+3.38%
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
2.45M
Relative Volume:
1.69
Marktkapitalisierung:
$220.42M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.6233
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
+47.20%
1M Leistung:
+76.87%
6M Leistung:
+55.92%
1J Leistung:
+2.16%
1-Tages-Spanne:
$2.03
$2.39
1-Wochen-Bereich:
$1.64
$2.39
52-Wochen-Spanne:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Vergleichen Sie CRBU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
2.37 | 149.74M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Caribou Biosciences Inc. Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com
Is Caribou Biosciences Inc. a good long term investmentSkyrocketing profit margins - jammulinksnews.com
What drives Caribou Biosciences Inc. stock priceAccelerated financial growth - PrintWeekIndia
What analysts say about Caribou Biosciences Inc. stockRapid return acceleration - jammulinksnews.com
Why Caribou Biosciences Inc. stock is on top investor watchlistsFast Gains With Reduced Risk - Newser
Citi reiterates Buy rating on Caribou Biosciences stock ahead of key data - Investing.com Australia
Caribou Biosciences: Key Data Updates Coming, But I'm Concerned About Near-Term Volatility - Seeking Alpha
Investors Can Still File Late Claims in Caribou Bioscience Settlement — Here’s How to Get Your Share - TradingView
Rachel Haurwitz - Forbes
Why Caribou Biosciences Inc. stock attracts strong analyst attentionRisk Adjusted Stock Signals - Newser
How Caribou Biosciences Inc. stock performs during market volatilityTriple Return With Stability - Newser
What makes Caribou Biosciences Inc. stock price move sharplyVerified Return Tips - Newser
Caribou Biosciences(CRBU) soars 9.38% on FDA clearance, institutional interest - AInvest
Caribou Biosciences shares rise 1.88% in premarket after being listed as one of four stocks poised to ride the 2025 biotech growth wave. - AInvest
Biotech Sector Shows Promising Growth with Key Players Leading Innovation - citybuzz -
Caribou Biosciences (CRBU) Is Paying a $3.9M Settlement to Investors — Here’s How to Get Your Share - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. LawsuitCRBU - ACCESS Newswire
Caribou Biosciences Regains Nasdaq Compliance, Maintains Minimum Closing Bid Price - AInvest
Caribou Biosciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com UK
Discovering RF Industries And 2 Other Promising Penny Stocks - simplywall.st
Caribou Biosciences Announces Director Elections and Auditor Confirmation - AInvest
Caribou Biosciences Confirms Director Elections and Auditor - TipRanks
Analysts Offer Predictions for CRBU FY2026 Earnings - Defense World
Caribou Biosciences (NASDAQ:CRBU) versus AlloVir (NASDAQ:ALVR) Critical Contrast - Defense World
Public Employees Retirement System of Ohio Takes $222,000 Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Nuveen Asset Management LLC Acquires 63,096 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionCRBU - ACCESS Newswire
Millennium Management LLC Has $1.37 Million Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Ameriprise Financial Inc. Purchases New Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
CRISPR Market Research and Competitive Landscape Report 2025Global Forecast to 2030: Rising Adoption in Research and Therapy Drives Growth with Thermo Fisher Scientific and Merck Leading - GlobeNewswire
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Sells 2,800,953 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Holdings Lowered by Jane Street Group LLC - Defense World
Northern Trust Corp Boosts Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference - The Manila Times
Caribou Biosciences CEO Fireside Chat: Latest CRISPR Innovations at Jefferies Conference - Stock Titan
Caribou Biosciences’ SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com South Africa
Caribou Biosciences’ SWOT analysis: biotech stock faces pivotal moment - Investing.com
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):